These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37735874)

  • 1. METTL5-mediated 18S rRNA m
    Dai Z; Zhu W; Hou Y; Zhang X; Ren X; Lei K; Liao J; Liu H; Chen Z; Peng S; Li S; Lin S; Kuang M
    Mol Ther; 2023 Nov; 31(11):3225-3242. PubMed ID: 37735874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N
    Peng H; Chen B; Wei W; Guo S; Han H; Yang C; Ma J; Wang L; Peng S; Kuang M; Lin S
    Nat Metab; 2022 Aug; 4(8):1041-1054. PubMed ID: 35999469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The METTL5-TRMT112 N
    Sepich-Poore C; Zheng Z; Schmitt E; Wen K; Zhang ZS; Cui XL; Dai Q; Zhu AC; Zhang L; Sanchez Castillo A; Tan H; Peng J; Zhuang X; He C; Nachtergaele S
    J Biol Chem; 2022 Mar; 298(3):101590. PubMed ID: 35033535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N
    Chen B; Huang Y; He S; Yu P; Wu L; Peng H
    Cell Chem Biol; 2023 Feb; 30(2):144-158.e10. PubMed ID: 36800991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 18S rRNA m
    Xing M; Liu Q; Mao C; Zeng H; Zhang X; Zhao S; Chen L; Liu M; Shen B; Guo X; Ma H; Chen H; Zhang J
    EMBO Rep; 2020 Oct; 21(10):e49863. PubMed ID: 32783360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosome 18S m
    Huang H; Li H; Pan R; Wang S; Khan AA; Zhao Y; Zhu H; Liu X
    Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34970694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribosome 18S m
    Rong B; Zhang Q; Wan J; Xing S; Dai R; Li Y; Cai J; Xie J; Song Y; Chen J; Zhang L; Yan G; Zhang W; Gao H; Han JJ; Qu Q; Ma H; Tian Y; Lan F
    Cell Rep; 2020 Dec; 33(12):108544. PubMed ID: 33357433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation.
    Huang X; Zhu L; Wang L; Huang W; Tan L; Liu H; Huo J; Su T; Zhang M; Kuang M; Li X; Dai Z; Xu L
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1156-1168. PubMed ID: 35233828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mettl5 mediated 18S rRNA N6-methyladenosine (m
    Wang L; Liang Y; Lin R; Xiong Q; Yu P; Ma J; Cheng M; Han H; Wang X; Wang G; Liang F; Pei Z; Chen D; Yuan Q; Jiang YZ; Lin S
    Genes Dis; 2022 Jan; 9(1):268-274. PubMed ID: 35005123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N
    Dai Z; Liu H; Liao J; Huang C; Ren X; Zhu W; Zhu S; Peng B; Li S; Lai J; Liang L; Xu L; Peng S; Lin S; Kuang M
    Mol Cell; 2021 Aug; 81(16):3339-3355.e8. PubMed ID: 34352206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.
    Huang CS; Zhu YQ; Xu QC; Chen S; Huang Y; Zhao G; Ni X; Liu B; Zhao W; Yin XY
    Clin Transl Med; 2022 Jun; 12(6):e848. PubMed ID: 35696608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m
    Zhou S; Yang K; Chen S; Lian G; Huang Y; Yao H; Zhao Y; Huang K; Yin D; Lin H; Li Y
    J Transl Med; 2023 Jan; 21(1):43. PubMed ID: 36691046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of m
    Han Y; Du T; Guo S; Wang L; Dai G; Long T; Xu T; Zhuang X; Liu C; Li S; Zhang D; Liao X; Dong Y; Lui KO; Tan X; Lin S; Chen Y; Huang ZP
    Front Cardiovasc Med; 2022; 9():852775. PubMed ID: 35295259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rRNA m
    Ignatova VV; Stolz P; Kaiser S; Gustafsson TH; Lastres PR; Sanz-Moreno A; Cho YL; Amarie OV; Aguilar-Pimentel A; Klein-Rodewald T; Calzada-Wack J; Becker L; Marschall S; Kraiger M; Garrett L; Seisenberger C; Hölter SM; Borland K; Van De Logt E; Jansen PWTC; Baltissen MP; Valenta M; Vermeulen M; Wurst W; Gailus-Durner V; Fuchs H; Hrabe de Angelis M; Rando OJ; Kellner SM; Bultmann S; Schneider R
    Genes Dev; 2020 May; 34(9-10):715-729. PubMed ID: 32217665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
    Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
    J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging importance of METTL5-mediated ribosomal RNA methylation.
    Turkalj EM; Vissers C
    Exp Mol Med; 2022 Oct; 54(10):1617-1625. PubMed ID: 36266443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.
    Shimizu T; Yokomuro S; Mizuguchi Y; Kawahigashi Y; Arima Y; Taniai N; Mamada Y; Yoshida H; Akimaru K; Tajiri T
    World J Gastroenterol; 2006 Oct; 12(39):6316-24. PubMed ID: 17072955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL5-mediated 18S rRNA m
    Li Z; Jiang A; Fang J; Jiang Y; He W; Yan L; Qiu S; Qin B; Zhu Q; Wang H
    Exp Neurol; 2025 Jan; 383():115000. PubMed ID: 39406306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.
    Xu H; Lin X; Li Z; He X; Li Y; Qiu L; Lu L; Liu B; Zhan M; He K
    J Gastroenterol; 2023 Sep; 58(9):925-944. PubMed ID: 37391589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.